Correlation Between DXC Technology and ImmuPharma PLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both DXC Technology and ImmuPharma PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DXC Technology and ImmuPharma PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DXC Technology Co and ImmuPharma PLC, you can compare the effects of market volatilities on DXC Technology and ImmuPharma PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DXC Technology with a short position of ImmuPharma PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of DXC Technology and ImmuPharma PLC.

Diversification Opportunities for DXC Technology and ImmuPharma PLC

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between DXC and ImmuPharma is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding DXC Technology Co and ImmuPharma PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ImmuPharma PLC and DXC Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DXC Technology Co are associated (or correlated) with ImmuPharma PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ImmuPharma PLC has no effect on the direction of DXC Technology i.e., DXC Technology and ImmuPharma PLC go up and down completely randomly.

Pair Corralation between DXC Technology and ImmuPharma PLC

Assuming the 90 days trading horizon DXC Technology is expected to generate 43.87 times less return on investment than ImmuPharma PLC. But when comparing it to its historical volatility, DXC Technology Co is 22.67 times less risky than ImmuPharma PLC. It trades about 0.12 of its potential returns per unit of risk. ImmuPharma PLC is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest  123.00  in ImmuPharma PLC on October 28, 2024 and sell it today you would earn a total of  282.00  from holding ImmuPharma PLC or generate 229.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

DXC Technology Co  vs.  ImmuPharma PLC

 Performance 
       Timeline  
DXC Technology 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in DXC Technology Co are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, DXC Technology is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
ImmuPharma PLC 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in ImmuPharma PLC are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical and fundamental indicators, ImmuPharma PLC exhibited solid returns over the last few months and may actually be approaching a breakup point.

DXC Technology and ImmuPharma PLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with DXC Technology and ImmuPharma PLC

The main advantage of trading using opposite DXC Technology and ImmuPharma PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DXC Technology position performs unexpectedly, ImmuPharma PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ImmuPharma PLC will offset losses from the drop in ImmuPharma PLC's long position.
The idea behind DXC Technology Co and ImmuPharma PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments